SPS
FLGT icon

Susquehanna Portfolio Strategies’s Fulgent Genetics FLGT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$459K Sell
28,859
-9,621
-25% -$209K 0.01% 771
2025
Q4 		$1.01M Buy
38,480
+4,560
+13% +$118K 0.02% 642
2025
Q3 		$767K Sell
33,920
-9,403
-22% -$194K 0.01% 741
2025
Q2 		$861K Buy
+43,323
New +$844K 0.02% 542

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna Portfolio Strategies's FLGT Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Fulgent Genetics (FLGT) stake by 25% in Q1 2026, selling an estimated $209K and leaving 28,859 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #771.

Susquehanna Portfolio Strategies first reported a position in FLGT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.01M in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Susquehanna Portfolio Strategies held 28,859 shares of Fulgent Genetics worth $459K as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 9,621 Fulgent Genetics shares in Q1 2026, an estimated $209K.
  • Fulgent Genetics made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #771 holding.
  • Susquehanna Portfolio Strategies first reported a position in Fulgent Genetics in Q2 2025 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's Fulgent Genetics position peaked at $1.01M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.